| |  Online-Ressource |
|---|
| Verfasst von: | Schirmbeck, Nadine [VerfasserIn]  |
|---|
| | Mey, Ulrich J. M. [VerfasserIn] |
|---|
| | Olivieri, Attilio [VerfasserIn] |
|---|
| | Ko, Yon-Dschun [VerfasserIn] |
|---|
| | Kaiser, Ulrich [VerfasserIn] |
|---|
| | Flieger, Dimitri [VerfasserIn] |
|---|
| | Witzens-Harig, Mathias [VerfasserIn] |
|---|
| | Schmidt-Wolf, Ingo G. H. [VerfasserIn] |
|---|
| Titel: | Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma |
|---|
| Verf.angabe: | Nadine G.D. Schirmbeck, Ulrich J.M. Mey, Attilio Olivieri, Yon-Dschun Ko, Ulrich Kaiser, Dimitri Flieger, Mathias Witzens-Harig, Ingo G.H. Schmidt-Wolf |
|---|
| E-Jahr: | 2016 |
|---|
| Jahr: | 16 Sep 2016 |
|---|
| Umfang: | 12 S. |
|---|
| Fussnoten: | Gesehen am 14.05.2020 |
|---|
| Titel Quelle: | Enthalten in: Cancer investigation |
|---|
| Ort Quelle: | Abingdon : Taylor & Francis Group, 1983 |
|---|
| Jahr Quelle: | 2016 |
|---|
| Band/Heft Quelle: | 34(2016), 8, Seite 361-372 |
|---|
| ISSN Quelle: | 1532-4192 |
|---|
| Abstract: | This analysis reports on 72 patients with relapsed or refractory non-Hodgkin lymphoma who were treated with R-DHAP salvage chemotherapy regimen followed by high-dose chemotherapy and stem cell transplantation. The overall remission rate was 58.3%. Median time of follow-up was 28.7 months. Median progression-free survival was 29 months, estimated median overall survival was 37 months. Within a matched pair analysis these results were compared to a group that received DHAP salvage therapy without rituximab showing similar overall response rates and better estimated five-year overall survival of 59.2% versus 43.5%. R-DHAP therapy was shown to be effective and feasible with acceptable toxicity. |
|---|
| DOI: | doi:10.1080/07357907.2016.1212062 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1080/07357907.2016.1212062 |
|---|
| | Volltext: https://www.tandfonline.com/doi/full/10.1080/07357907.2016.1212062 |
|---|
| | DOI: https://doi.org/10.1080/07357907.2016.1212062 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Lymphomas |
|---|
| | therapy |
|---|
| | treatment |
|---|
| | tumor immunology |
|---|
| K10plus-PPN: | 1698280335 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma / Schirmbeck, Nadine [VerfasserIn]; 16 Sep 2016 (Online-Ressource)
